Compare DFTX & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DFTX | RITM |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.3B |
| IPO Year | 2020 | 2012 |
| Metric | DFTX | RITM |
|---|---|---|
| Price | $30.21 | $8.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 10 |
| Target Price | ★ $72.83 | $12.80 |
| AVG Volume (30 Days) | 1.5M | ★ 6.3M |
| Earning Date | 11-09-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $4,590,228,000.00 |
| Revenue This Year | N/A | $63.34 |
| Revenue Next Year | N/A | $4.17 |
| P/E Ratio | ★ N/A | $16.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.62 | $8.31 |
| 52 Week High | $49.70 | $12.15 |
| Indicator | DFTX | RITM |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 42.21 |
| Support Level | $20.43 | $8.37 |
| Resistance Level | $38.59 | $9.56 |
| Average True Range (ATR) | 2.10 | 0.24 |
| MACD | -0.21 | -0.04 |
| Stochastic Oscillator | 3.34 | 2.39 |
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.